Cholangiocarcinoma News

Gordon T Moffat, MD, FRCPC

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre; Department of Oncology, University of Toronto, Toronto, Ontario, Canada

Authored Items

Combined Hepatocellular Cholangiocarcinoma
Jennifer J Knox, MD, MSc, FRCPC, Gordon T Moffat, MD, FRCPC
From the Advisory Board
June 2023, Vol 4, No 2 — June 30, 2023
Combined hepatocellular cholangiocarcinoma (cHCC-CCA) is a unique malignancy comprised of both hepatocellular carcinoma (HCC) from hepatocytes and cholangiocarcinoma (CCA) from bile duct epithelial cells within the same tumor. Initially thought to be a rare entity, the incidence is increasing (up to 14%), yet recognition remains low.
Read More

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly CCA News print publication and CCA News weekly e‑newsletter.

© Amplity Health. All Rights Reserved. Privacy Policy.